Vesalius Cardiovascular Inc. filed a Form D with the Securities and Exchange Commission on 2025-08-22.
Vesalius Cardiovascular Inc. filed a Form D notice of an exempt securities offering with the SEC on August 22, 2025. The filing reports $50K sold. Its industry group is Other Technology. It names Peter Skarsgard (Director, Promoter), Vincent Ledoux (Director, Executive Officer) (SEC Form D, August 22, 2025).
Is this your company?
Sell to companies like Vesalius Cardiovascular Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-08-22 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Vesalius Cardiovascular Inc.
Free to see. No signup.
More on the people and the money behind Vesalius Cardiovascular Inc., from the filings we hold.
Other Technology raises by companies based in the British Columbia, Canada, filed within 90 days of this one, largest first.
Get an email when Vesalius Cardiovascular Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Vesalius Cardiovascular Inc. raises, hires or launches. No email unless you switch it on.
Watch Vesalius Cardiovascular Inc. →Get the full cited report on Vesalius Cardiovascular Inc.
What the filing shows about Vesalius Cardiovascular Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Vesalius Cardiovascular Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Vesalius Cardiovascular Inc.'s address as 210 West Broadway, Unit 200, Vancouver, A1 V5Y 3W2.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Vesalius Cardiovascular Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Vesalius Cardiovascular Inc. See pricing
Vesalius Cardiovascular Inc. is a registered filer with the SEC (CIK 1904804) and has filed since 2023-09-22. 4 filings are on record, the latest on 2025-08-29.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Vesalius Cardiovascular Inc.'s Form D of 2025-08-22 names Peter Skarsgard and Vincent Ledoux as its officers, directors or promoters.
Its new offerings report $88K sold across 2 offerings, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 3844 filings in Other Technology, totalled by week.
Peter Skarsgard is named as Director and Promoter on the Form D that Vesalius Cardiovascular Inc. filed with the SEC on 22 August 2025, one of 2 people that filing names.
Vincent Ledoux is named as Director and Executive Officer on the Form D that Vesalius Cardiovascular Inc. filed with the SEC on 22 August 2025, one of 2 people that filing names.
2 people named on the filing — 1 holding an executive role and 1 as a director only.
Named as of the 2025-08-22 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
What the filing shows about Vesalius Cardiovascular Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Vesalius Cardiovascular Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Vesalius Cardiovascular Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Vesalius Cardiovascular Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Vesalius Cardiovascular Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Vesalius Cardiovascular Inc.. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/vesalius-cardiovascular-inc-form-d-25000001